Previous track Next track

Current and future challenges in global drug policy

In programme

16 sessions 69 presentations View the programme

About

This track is co-produced by the International Society for the Study of Drug Policy (ISSDP).

Current and future challenges in national, regional or global drug policy (UN Sustainable Development Goals, reducing inequalities).
Development, dissemination and funding of evidence-based, comprehensive and affordable drug treatments
Cannabis regulation and cannabis policy innovations.
Positive and negative spillover effects of drug policies and drug markets across the globe.
The challenge of measuring drug policy and drug policy effectiveness.

Sessions

Wednesday, 23 November

10:50

Current and future challenges associated with emerging cannabis markets

Structured session

13:20

Policies for regulating cannabis supply in Europe and the US: the need for appropriate monitoring and evaluation

Knowledge market 1 (K1)

Structured session

15:00

Implementation of quality standards in drug demand reduction – where we are and where we are going?

Knowledge market 1 (K1)

Structured session

Spillover effects of drug policy and why better data are needed

Networking zone 1 (N1)

e-poster guided tour

16:50

Assessment of drug policies in light of Sustainable Development Goals and human rights

Knowledge market 1 (K1)

Structured session

Thursday, 24 November

09:00

Developing the addiction workforce in Africa: Progress and Issues

Central square 4 (C4)

10:50

Cannabis use and purchase behaviours in Canada, United States, Australia, and New Zealand: Findings from the International Cannabis Policy Study

Knowledge market 1 (K1)

Structured session

New frontiers of harm reduction in drug policy

Networking zone 2 (N2)

e-poster guided tour

13:20

Cannabis Social Clubs: current experiences and future directions

Knowledge market 4 (K4)

Structured session

15:00

Drug deaths: A social, structural and systems analysis

Knowledge market 1 (K1)

Structured session

16:50

Innovative approaches to tackling the drug overdoses

Knowledge market 1 (K1)

Oral presentation session

New frontiers to regulating cannabis for public health and social justice

Insights zone 2 (I2)

Oral presentation session

Trajectories of cannabis use during periods of policy change

Central square 2 (C2)

Oral presentation session

Friday, 25 November

10:50

A Digital Future? Engaging online communities of people who use drugs to influence policy and practice

Central square 4 (C4)

Language values and theory in drugs policy reform

Knowledge market 1 (K1)

Oral presentation session

13:20

Using innovative data or methods to assess drug markets and drug policy impacts

Knowledge market 1 (K1)

Oral presentation session

Presentations

Wednesday, 23 November

13:20

Oral presentation

3. The Swiss pilot trials with cannabis – evaluation after one year

Knowledge market 1 (K1)

Oral presentation

4. The Dutch closed cannabis supply chain experiment: background, design of the evaluation study and challenges

Knowledge market 1 (K1)

Margriet van Laar

Adapting monitoring and evaluation to the different versions of 'legalisation', while exploring possible common indicators

Knowledge market 1 (K1)

Oral presentation

5. The U.S. Cannabis Policy Scale: Moving Beyond Dichotomous Measures to Evaluate Impacts of Liberalization Policies on Cannabis and Other Substance Use Outcomes

Knowledge market 1 (K1)

Oral presentation

2. Measuring the impacts of a new cannabis regulation in Luxembourg: the need for valid data collection methods

Knowledge market 1 (K1)

15:00

Quality Standards in Drug Demand Reduction – lessons learned and the way forward

Knowledge market 1 (K1)

Wouter Vanderplasschen

Oral presentation

1. Quality Assurance Tools: Improving Coverage, Accessibility and Quality of Drug Use Disorder Treatment

Knowledge market 1 (K1)

Oral presentation

4. Key factors for a successful implementation of Quality Standards in Drug Demand Reduction – a Delphi Study

Knowledge market 1 (K1)

Oral presentation

2. Further ENhancing the Implementation of Quality Standards in drug demand reduction across Europe (FENIQS-EU) project – study objectives and first realisations

Knowledge market 1 (K1)

Dijana Jerkovic

Oral presentation

3. State of the Art of Quality Standards implementation in drug demand reduction in Europe

Knowledge market 1 (K1)

Oral presentation

5. An inspiring practice example of Quality Standards implementation: the Spanish Good Practice inDemand Reduction Portal (PBBPP)

Knowledge market 1 (K1)

Alba González-Roz

Association of the 2016 UK Psychoactive Substance Act with hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure.

Networking zone 1 (N1)

Is there a long-term relationship between cannabis and heroin use? An 18-20-year follow-up of the Australian Treatment Outcome Study (ATOS)

Networking zone 1 (N1)

Regulating cannabis : a comparative perspective on policy rollouts and unintended consequences in The United States and Canada (lessons from 6 case studies)

Networking zone 1 (N1)

Ivana Obradovic

The Effects of Recreational Cannabis Laws on Pharmacy- and Hospital-Based Opioid Distribution in the United States

Networking zone 1 (N1)

16:50

Oral presentation

1. International Guidelines on Human Rights and Drug Policy: From standard setting to assessing compliance

Knowledge market 1 (K1)

Oral presentation

2. Pompidou Group for Human rights and drug policies in Europe: A self-assessment tool

Knowledge market 1 (K1)

Oral presentation

3. The Global Drug Policy Index: A unique accountability tool to assess and rank countries’ drug policies

Knowledge market 1 (K1)

Juan Fernandez Ochoa

Thursday, 24 November

09:00

Oral presentation

1. Needs Assessment of Addiction Science Programmes at Universities in South Africa and Preparatory work for curriculum development

Central square 4 (C4)

Oral presentation

2. Addiction Curriculum in Nigerian Higher Education System – Contextualizing Western-based methods and approaches for responsiveness and effectiveness.

Central square 4 (C4)

Oral presentation

3. Piloting an implementation protocol delivered as an online course: African leadership in addiction workforce development

Central square 4 (C4)

Beatrice Kathungu

10:50

Oral presentation

3. Perceptions of illegal and legal cannabis in Canada in the three years after cannabis legalization: Findings from the International Cannabis Policy Study

Knowledge market 1 (K1)

Why Social Science should matter for a pragmatic drug policy: Critical analysis of the drug policy debate in India, 1947-2020.

Networking zone 2 (N2)

Kawal Deep Kour

Alcohol industry’s arguments disseminated in the mainstream press against pregnancy alcohol warning labels in France

Networking zone 2 (N2)

Sin tax in Poland – an example of effectiveness of fiscal measures in alcohol policy

Networking zone 2 (N2)

Dagmara Lebiecka

Building harm reduction focused cannabis public education materials: An example of knowledge translation with previously stigmatized communities.

Networking zone 2 (N2)

Lessons for Public Health and Public Safety from Fentanyl-Related Substances Scheduling in the United States

Networking zone 2 (N2)

20 years of decriminalisation

Networking zone 2 (N2)

Américo Gegaloto

Oral presentation

1. The International Cannabis Policy Study – Framework for evaluating cannabis legalization

Knowledge market 1 (K1)

Oral presentation

2. Patterns of problematic cannabis use among Canadian and US respondents between 2018 and 2020: Findings from the International Cannabis Policy Study

Knowledge market 1 (K1)

Cesar Leos-Toro

13:20

Oral presentation

1. Cannabis Social Clubs in Europe: a transnational social movement network in the making?

Knowledge market 4 (K4)

Oral presentation

3. Legal or not: a comparative analysis of Belgian and Uruguayan CSC members’ profile and policy preferences

Knowledge market 4 (K4)

Oral presentation

4. Drug social clubs – the next social club generation?

Knowledge market 4 (K4)

Oral presentation

2. What are the barriers and prospects for establishing Cannabis Social Clubs in New Zealand?

Knowledge market 4 (K4)

15:00

Oral presentation

3. The role of Primary Care in the prevention of drug-related deaths: Patient and family member perspectives

Knowledge market 1 (K1)

What can a social, structural and systems analysis tell us about drug-related deaths and what are the implications for policy and addiction science?

Knowledge market 1 (K1)

Oral presentation

4. The role of Primary Care in the prevention of drug-related deaths: service provider perspectives

Knowledge market 1 (K1)

Oral presentation

5. Drug Policy and The Rise and Decline of Racial Stratification of Prescribing and Overdose Mortality

Knowledge market 1 (K1)

Oral presentation

1. Drug-related deaths among young people: a social, structural and systems autopsy

Knowledge market 1 (K1)

Aileen O'Gorman

Oral presentation

2. Drug-related deaths in prisons in England and Wales, 2015-2020: an examination of key trends and issues for policy and practice

Knowledge market 1 (K1)

16:50

Oral presentation

Adolescent cannabis use during a period of rapid policy change: Evidence from the US PATH Study

Central square 2 (C2)

Oral presentation

The role played by evidence on the effects of cannabis use in cannabis policy 1992-2022

Central square 2 (C2)

Oral presentation

Trajectories of Prescribed Medical Cannabis Filled Over Time

Central square 2 (C2)

Alexandra Kritikos

Oral presentation

The limitations of decriminalization at overdose events and lessons from an evaluation in British Columbia, Canada

Knowledge market 1 (K1)

Oral presentation

Medical cannabis regulation: Taking the best of the North American and European models

Insights zone 2 (I2)

Oral presentation

The change in methadone dispensing requirements in England during the first wave of the COVID-19 pandemic was associated with an increase in deaths from non-prescribed methadone

Knowledge market 1 (K1)

Caroline Copeland

Oral presentation

Municipal variations in cannabis regulation regarding public consumption and retail sales in Canada

Insights zone 2 (I2)

Christophe Huynh

Oral presentation

Long term public health benefits and cost-effectiveness of two experimental drug consumption rooms in France

Knowledge market 1 (K1)

Oral presentation

Québec's public, not-for-profit cannabis distribution regime: a comparative analysis, three years in

Insights zone 2 (I2)

François Gagnon

Oral presentation

The United Kingdom’s first unsanctioned safe injecting facility; a proof-of-concept evaluation

Knowledge market 1 (K1)

Gillian Shorter

Oral presentation

Regulating Cannabis for Public Health

Insights zone 2 (I2)

Oral presentation

First low-threshold gender responsive residential resource for homeless people using drugs in Barcelona: descriptive evaluation of the first 6 months of activity.

Knowledge market 1 (K1)

Gabriela Barbaglia

Oral presentation

Mitigating the risks of corporate capture in emerging legal cannabis markets

Insights zone 2 (I2)

Oral presentation

Equity in Marijuana Policies: A Comparative Study of two U.S. States using Critical Race Theory.

Insights zone 2 (I2)

Oral presentation

Differences in cannabis use and opinions on drug policy between generations

Central square 2 (C2)

Pekka Hakkarainen

Friday, 25 November

10:50

Oral presentation

Why did New Zealand’s referendum to legalise recreation cannabis fail? An analysis of media campaigns and predictors of voter support for cannabis legalisation in New Zealand

Knowledge market 1 (K1)

Oral presentation

Language matters and it starts with us: How to talk about drugs to advocate for reform more effectively

Knowledge market 1 (K1)

Oral presentation

The Policy Constellation Approach: application of a critical realist public policy theory to the explanation of the UK’s drug strategy for 2021-2031

Knowledge market 1 (K1)

Oral presentation

The utility of different values frameworks for drug policy analysis

Knowledge market 1 (K1)

Oral presentation

European Web Survey on Drugs

Central square 4 (C4)

João Matias, José Pedro Teixeira

Oral presentation

European Web Survey on Drugs - Luxembourg

Central square 4 (C4)

Rita Cardoso Seixas

Oral presentation

European Web Survey on Drugs - Ireland

Central square 4 (C4)

Oral presentation

The experience of running web surveys in Belgium

Central square 4 (C4)

Oral presentation

Web surveys on drugs - how can these be important for those who use drugs

Central square 4 (C4)

13:20

Oral presentation

Cannabis regulation and fiscal policy: Opportunities for human rights in Colombia

Knowledge market 1 (K1)

Luis Felipe Cruz-olivera

Oral presentation

Prioritising measures to assess performance of drug treatment services: perspectives of funders, treatment providers and service users

Knowledge market 1 (K1)

Robert Stirling

Oral presentation

Tracking the illicit Cannabis Market during the closed Cannabis Supply Chain Experiment in Netherlands using an online Crowdsourcing Approach

Knowledge market 1 (K1)

Oral presentation

The effects of cannabis liberalization laws on health, safety, and socioeconomic outcomes: An evidence and gap map

Knowledge market 1 (K1)

Oral presentation

Triangulating wastewater and a prospective survey of drug consumption – new insights for policy makers

Knowledge market 1 (K1)

Previous track View all tracks Next track